BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38037430)

  • 1. The capsid revolution.
    Taylor IA; Fassati A
    J Mol Cell Biol; 2024 Apr; 15(11):. PubMed ID: 38037430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lenacapavir: a first-in-class HIV-1 capsid inhibitor.
    Dvory-Sobol H; Shaik N; Callebaut C; Rhee MS
    Curr Opin HIV AIDS; 2022 Jan; 17(1):15-21. PubMed ID: 34871187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid HIV-1 genotyping assay for the detection of capsid mutations.
    Margot N; Naik V; Nekkalapudi A; Boopathy A; Falkard B; Callebaut C
    J Med Virol; 2023 Dec; 95(12):e29292. PubMed ID: 38063404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Capsid in the Early Steps of HIV-1 Infection: New Insights into the Core of the Matter.
    AlBurtamani N; Paul A; Fassati A
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34204384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 CA Inhibitors Are Antagonized by Inositol Phosphate Stabilization of the Viral Capsid in Cells.
    Sowd GA; Shi J; Aiken C
    J Virol; 2021 Nov; 95(24):e0144521. PubMed ID: 34613803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Capsid and Integration Targeting.
    Engelman AN
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HIV-1 capsid and reverse transcription.
    Aiken C; Rousso I
    Retrovirology; 2021 Sep; 18(1):29. PubMed ID: 34563203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74.
    Saito A; Ferhadian D; Sowd GA; Serrao E; Shi J; Halambage UD; Teng S; Soto J; Siddiqui MA; Engelman AN; Aiken C; Yamashita M
    J Virol; 2016 Jun; 90(12):5808-5823. PubMed ID: 27076642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly.
    Price AJ; Jacques DA; McEwan WA; Fletcher AJ; Essig S; Chin JW; Halambage UD; Aiken C; James LC
    PLoS Pathog; 2014 Oct; 10(10):e1004459. PubMed ID: 25356722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
    Thenin-Houssier S; Valente ST
    Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Capsid Rapidly Induces Long-Lived CPSF6 Puncta in Non-Dividing Cells, but Similar Puncta Already Exist in Uninfected T-Cells.
    Guedán A; Burley M; Caroe ER; Bishop KN
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capsid-host interactions for HIV-1 ingress.
    Jang S; Engelman AN
    Microbiol Mol Biol Rev; 2023 Dec; 87(4):e0004822. PubMed ID: 37750702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenacapavir: A first-in-class capsid inhibitor for the treatment of highly treatment-resistant HIV.
    Prather C; Lee A; Yen C
    Am J Health Syst Pharm; 2023 Dec; 80(24):1774-1780. PubMed ID: 37767713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of HIV-1 Capsid with Host Factors and Their Implications for Developing Novel Therapeutics.
    Zhuang S; Torbett BE
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Host Cell Metabolite Inositol Hexakisphosphate Promotes Efficient Endogenous HIV-1 Reverse Transcription by Stabilizing the Viral Capsid.
    Jennings J; Shi J; Varadarajan J; Jamieson PJ; Aiken C
    mBio; 2020 Dec; 11(6):. PubMed ID: 33262260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenacapavir: A novel injectable HIV-1 capsid inhibitor.
    Hitchcock AM; Kufel WD; Dwyer KAM; Sidman EF
    Int J Antimicrob Agents; 2024 Jan; 63(1):107009. PubMed ID: 37844807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capsid-CPSF6 Interaction Is Dispensable for HIV-1 Replication in Primary Cells but Is Selected during Virus Passage In Vivo.
    Saito A; Henning MS; Serrao E; Dubose BN; Teng S; Huang J; Li X; Saito N; Roy SP; Siddiqui MA; Ahn J; Tsuji M; Hatziioannou T; Engelman AN; Yamashita M
    J Virol; 2016 Aug; 90(15):6918-6935. PubMed ID: 27307565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 capsid inhibitors: a sword to destroy the virus.
    Zhang X; Xu S; Sun L; Ding D; Tao Y; Kang D; Liu X; Zhan P
    Future Med Chem; 2022 May; 14(9):605-607. PubMed ID: 35297282
    [No Abstract]   [Full Text] [Related]  

  • 19. Roles of HIV-1 capsid in viral replication and immune evasion.
    Le Sage V; Mouland AJ; Valiente-Echeverría F
    Virus Res; 2014 Nov; 193():116-29. PubMed ID: 25036886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 Capsid: From Structural Component to Key Factor for Host Nuclear Invasion.
    Scoca V; Di Nunzio F
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33578999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.